Anzeige
Mehr »
Dienstag, 30.09.2025 - Börsentäglich über 12.000 News
Breaking News: Golden Cross entdeckt hochgradiges Gold - Ein neues Fosterville im Milliarden-Dollar-Gürtel von Victoria?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CND6 | ISIN: US90364P1057 | Ticker-Symbol: 9UV
Tradegate
30.09.25 | 18:44
11,800 Euro
+10,14 % +1,086
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
UIPATH INC Chart 1 Jahr
5-Tage-Chart
UIPATH INC 5-Tage-Chart
RealtimeGeldBriefZeit
11,75411,80818:45
11,74611,80018:45
ACCESS Newswire
157 Leser
Artikel bewerten:
(1)

AGS Health Earns Consecutive UiPath AI25 Award for Breakthroughs in Healthcare Denial Management

WASHINGTON, D.C. / ACCESS Newswire / September 30, 2025 / AGS Health, a leading provider of tech-enabled revenue cycle management (RCM) solutions and a strategic growth partner to healthcare providers across the U.S., has been named a recipient of the UiPath AI25 Award for its pioneering use of agentic AI automation to assist healthcare providers in managing the rising rate of costly healthcare claim denials.

Through their Denial Management Agents, AGS Health helps healthcare providers to reduce preventable denials, expedite appeals, and improve clean claim rates, projecting gains of up to 6 percent in clean claims and 20-26 percent faster handling times. This achievement, which marks the company's second consecutive UiPath AI25 Award following recognition in 2024, reflects its innovative hybrid workforce model where UiPath bots, AI agents, and skilled human specialists work seamlessly across critical RCM workflows such as prior authorization validation, denial classification and follow-up, medical necessity rejections, and timely filing checks. In this model, AI agents handle analysis and reasoning, bots manage routine tasks, and human experts oversee high-risk cases, audit, and quality control, ensuring efficiency and accuracy.

"These winners are breaking new ground with agentic automation. They're orchestrating people, AI, and robots to transform processes and deliver measurable impact," said Graham Sheldon, Chief Product Officer at UiPath and Executive Sponsor for the AI25 Awards. "We're proud to recognize their achievements and excited to see how they continue pushing the boundaries of what's possible."

The UiPath AI25 Awards spotlight the 25 most innovative implementations of the UiPath Platform for agentic automation. Winners demonstrate measurable ROI, productivity gains, and transformative business impact by orchestrating agents, bots, and people. Recognition spans both proven outcomes and promising early-stage initiatives that showcase the future of automation.

"AGS Health has embraced the healthcare industry's shift toward autonomous operations while keeping human expertise at the center," says Patrice Wolfe, CEO of AGS Health. "Our hybrid intelligence approach merges the speed and scalability of AI agents with the judgment and empathy of skilled professionals. This recognition by UiPath reaffirms our focus on building smarter, faster, and more autonomous processes that increase accuracy, efficiency, and financial performance with expert human oversight.

Adds AGS Health CIO Thomas Thatapudi, "Agentic automation enables us to deliver faster, more accurate RCM services, which is crucial for healthcare providers navigating cost pressures and rising claim volumes. By automating high-volume, error-prone tasks, we're helping reduce denials and improve first-pass rates, directly enhancing our customers' cash flow."

About AGS Health

AGS Health is more than a revenue cycle management company-we're a strategic partner for growth. Our distinctive methodology blends award-winning services with intelligent automation and high-touch customer support to deliver peak end-to-end revenue cycle performance and an empowering patient financial experience.

We employ a team of 15,000 highly trained and college-educated RCM experts who directly support customers spanning a variety of care settings and specialties, including nearly half of the 20 most prominent U.S. hospitals and 40% of the nation's 10 largest health systems. Our thoughtfully crafted RCM solutions deliver measurable revenue growth and retention, enabling customers to achieve the revenue to realize their vision.

# # #

Media Contact:

Liz Goar, NPC Creative Services
liz@npccs.com

SOURCE: AGS Health



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/ags-healthr-earns-consecutive-uipath-ai25-award-for-breakthroughs-in-1079904

© 2025 ACCESS Newswire
Epische Goldpreisrallye
Der Goldpreis hat ein neues Rekordhoch überschritten. Die Marke von 3.500 US-Dollar ist gefallen, und selbst 4.000 US-Dollar erscheinen nur noch als Zwischenziel.

Die Rallye wird von mehreren Faktoren gleichzeitig getrieben:
  • · massive Käufe durch Noten- und Zentralbanken
  • · Kapitalflucht in sichere Häfen
  • · hohe Nachfrage nach physisch besicherten Gold-ETFs
  • · geopolitische Unsicherheit und Inflationssorgen

Die Aktienkurse vieler Goldproduzenten und Explorer sind in den vergangenen Wochen regelrecht explodiert.

Doch es gibt noch Titel, die Nachholpotenzial besitzen. In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Goldaktien jetzt besonders aussichtsreich sind und warum der Aufwärtstrend noch lange nicht vorbei sein dürfte.

Laden Sie jetzt den Spezialreport kostenlos herunter und profitieren Sie von der historischen Gold-Hausse.

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.